Treatment outcomes and unmet needs in patients with acute myeloid leukemia (AML) who are ineligible for intensive induction chemotherapy (IC): A systematic literature review (SLR)
By downloading this material, you acknowledge that this action may be considered a transfer of value and will be reported by Taiho Oncology, Inc. in accordance with applicable Transparency and Sunshine Act requirements.